Biocon’s Oral Insulin Gains Momentum With JDRF Backing

 
• By Anju Ghangurde
  
Diabetes
BIOCON's ORAL INSULIN PLAN IS BEING BACKED BY JDRF
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapy Areas